Tuesday, July 6, 2010

Partnerships Asia Pacific Session Spotlight: Partnerships in Clinical Trials: East vs. West

Each week leading up to Partnerships in Clinical Trials Asia Pacific, we'll be highlighting a session from the upcoming conference. It will take place October 5-7, 2010, in Singapore. For more information, visit our webpage to download the brochure.

Featured Session: Partnerships in Clinical Trials: East vs. West
Presented by: Mark Bach, PhD, Vice President, Head of R&D, Regulatory Affairs and Safety,
JANSSEN PHARMACEUTICALS KK, Japan

About the session:
Pharmaceutical companies are facing continuing pressure due to patent expirations, increasing regulatory constraints and other factors. These result in the need to increase productivity, increase speed to market and maintain quality. One approach to address these needs is strategic sourcing – CROs can bring value to sponsors through both strategic and tactical support for development. Sponsors headquartered in the US and Europe are entering into strategic partnerships with CROs, but the experience in Asia is more limited. How can the extensive experience in these markets inform and accelerate the development of such relationships in Asia?

Key issues include:
• How does the current APAC environment compare to the US/EU CRO industry 10 years ago?
• How is the Asia operation model different from US?
• What can be learned from the history of CRO and pharma partnership development outside of Asia?

No comments:

Post a Comment